United States Vaccine Adjuvants Market Report 2017

December 2017 | 98 pages | ID: U966D6F4636EN
QYResearch

Abstracts

In this report, the United States Vaccine Adjuvants market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Vaccine Adjuvants in these regions, from 2012 to 2022 (forecast).

United States Vaccine Adjuvants market competition by top manufacturers/players, with Vaccine Adjuvants sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• SEPPIC
• SDA BIO
• Brenntag Biosector
• SPI Pharma
• MVP Laboratories
• Tj Kaiwei
• Novavax
• Zhuoyue
• Aphios

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Oral
• Subcutaneous
• Intramuscular
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Human Vaccine Adjuvants
• Veterinary Vaccine Adjuvants

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Vaccine Adjuvants Market Report 2017

1 VACCINE ADJUVANTS OVERVIEW

1.1 Product Overview and Scope of Vaccine Adjuvants
1.2 Classification of Vaccine Adjuvants by Product Category
  1.2.1 United States Vaccine Adjuvants Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Vaccine Adjuvants Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Oral
  1.2.4 Subcutaneous
  1.2.5 Intramuscular
  1.2.6 Others
1.3 United States Vaccine Adjuvants Market by Application/End Users
  1.3.1 United States Vaccine Adjuvants Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Human Vaccine Adjuvants
  1.3.3 Veterinary Vaccine Adjuvants
1.4 United States Vaccine Adjuvants Market by Region
  1.4.1 United States Vaccine Adjuvants Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Vaccine Adjuvants Status and Prospect (2012-2022)
  1.4.3 Southwest Vaccine Adjuvants Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Vaccine Adjuvants Status and Prospect (2012-2022)
  1.4.5 New England Vaccine Adjuvants Status and Prospect (2012-2022)
  1.4.6 The South Vaccine Adjuvants Status and Prospect (2012-2022)
  1.4.7 The Midwest Vaccine Adjuvants Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Vaccine Adjuvants (2012-2022)
  1.5.1 United States Vaccine Adjuvants Sales and Growth Rate (2012-2022)
  1.5.2 United States Vaccine Adjuvants Revenue and Growth Rate (2012-2022)

2 UNITED STATES VACCINE ADJUVANTS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Vaccine Adjuvants Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Vaccine Adjuvants Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Vaccine Adjuvants Average Price by Players/Suppliers (2012-2017)
2.4 United States Vaccine Adjuvants Market Competitive Situation and Trends
  2.4.1 United States Vaccine Adjuvants Market Concentration Rate
  2.4.2 United States Vaccine Adjuvants Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Vaccine Adjuvants Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES VACCINE ADJUVANTS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Vaccine Adjuvants Sales and Market Share by Region (2012-2017)
3.2 United States Vaccine Adjuvants Revenue and Market Share by Region (2012-2017)
3.3 United States Vaccine Adjuvants Price by Region (2012-2017)

4 UNITED STATES VACCINE ADJUVANTS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Vaccine Adjuvants Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Vaccine Adjuvants Revenue and Market Share by Type (2012-2017)
4.3 United States Vaccine Adjuvants Price by Type (2012-2017)
4.4 United States Vaccine Adjuvants Sales Growth Rate by Type (2012-2017)

5 UNITED STATES VACCINE ADJUVANTS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Vaccine Adjuvants Sales and Market Share by Application (2012-2017)
5.2 United States Vaccine Adjuvants Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES VACCINE ADJUVANTS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 SEPPIC
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Vaccine Adjuvants Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 SEPPIC Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 SDA BIO
  6.2.2 Vaccine Adjuvants Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 SDA BIO Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Brenntag Biosector
  6.3.2 Vaccine Adjuvants Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Brenntag Biosector Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 SPI Pharma
  6.4.2 Vaccine Adjuvants Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 SPI Pharma Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 MVP Laboratories
  6.5.2 Vaccine Adjuvants Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 MVP Laboratories Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Tj Kaiwei
  6.6.2 Vaccine Adjuvants Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Tj Kaiwei Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Novavax
  6.7.2 Vaccine Adjuvants Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Novavax Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Zhuoyue
  6.8.2 Vaccine Adjuvants Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Zhuoyue Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Aphios
  6.9.2 Vaccine Adjuvants Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Aphios Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview

7 VACCINE ADJUVANTS MANUFACTURING COST ANALYSIS

7.1 Vaccine Adjuvants Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Vaccine Adjuvants

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Vaccine Adjuvants Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Vaccine Adjuvants Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES VACCINE ADJUVANTS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Vaccine Adjuvants Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Vaccine Adjuvants Sales Volume Forecast by Type (2017-2022)
11.3 United States Vaccine Adjuvants Sales Volume Forecast by Application (2017-2022)
11.4 United States Vaccine Adjuvants Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Vaccine Adjuvants
Figure United States Vaccine Adjuvants Market Size (Units) by Type (2012-2022)
Figure United States Vaccine Adjuvants Sales Volume Market Share by Type (Product Category) in 2016
Figure Oral Product Picture
Figure Subcutaneous Product Picture
Figure Intramuscular Product Picture
Figure Others Product Picture
Figure United States Vaccine Adjuvants Market Size (Units) by Application (2012-2022)
Figure United States Sales Market Share of Vaccine Adjuvants by Application in 2016
Figure Human Vaccine Adjuvants Examples
Table Key Downstream Customer in Human Vaccine Adjuvants
Figure Veterinary Vaccine Adjuvants Examples
Table Key Downstream Customer in Veterinary Vaccine Adjuvants
Figure United States Vaccine Adjuvants Market Size (Million USD) by Region (2012-2022)
Figure The West Vaccine Adjuvants Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Vaccine Adjuvants Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Vaccine Adjuvants Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Vaccine Adjuvants Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Vaccine Adjuvants Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Vaccine Adjuvants Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Vaccine Adjuvants Sales (Units) and Growth Rate (2012-2022)
Figure United States Vaccine Adjuvants Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Vaccine Adjuvants Market Major Players Product Sales Volume (Units) (2012-2017)
Table United States Vaccine Adjuvants Sales (Units) of Key Players/Suppliers (2012-2017)
Table United States Vaccine Adjuvants Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Vaccine Adjuvants Sales Share by Players/Suppliers
Figure 2017 United States Vaccine Adjuvants Sales Share by Players/Suppliers
Figure United States Vaccine Adjuvants Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Vaccine Adjuvants Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Vaccine Adjuvants Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Vaccine Adjuvants Revenue Share by Players/Suppliers
Figure 2017 United States Vaccine Adjuvants Revenue Share by Players/Suppliers
Table United States Market Vaccine Adjuvants Average Price (K USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Vaccine Adjuvants Average Price (K USD/Unit) of Key Players/Suppliers in 2016
Figure United States Vaccine Adjuvants Market Share of Top 3 Players/Suppliers
Figure United States Vaccine Adjuvants Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Vaccine Adjuvants Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Vaccine Adjuvants Product Category
Table United States Vaccine Adjuvants Sales (Units) by Region (2012-2017)
Table United States Vaccine Adjuvants Sales Share by Region (2012-2017)
Figure United States Vaccine Adjuvants Sales Share by Region (2012-2017)
Figure United States Vaccine Adjuvants Sales Market Share by Region in 2016
Table United States Vaccine Adjuvants Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Vaccine Adjuvants Revenue Share by Region (2012-2017)
Figure United States Vaccine Adjuvants Revenue Market Share by Region (2012-2017)
Figure United States Vaccine Adjuvants Revenue Market Share by Region in 2016
Table United States Vaccine Adjuvants Price (K USD/Unit) by Region (2012-2017)
Table United States Vaccine Adjuvants Sales (Units) by Type (2012-2017)
Table United States Vaccine Adjuvants Sales Share by Type (2012-2017)
Figure United States Vaccine Adjuvants Sales Share by Type (2012-2017)
Figure United States Vaccine Adjuvants Sales Market Share by Type in 2016
Table United States Vaccine Adjuvants Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Vaccine Adjuvants Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Vaccine Adjuvants by Type (2012-2017)
Figure Revenue Market Share of Vaccine Adjuvants by Type in 2016
Table United States Vaccine Adjuvants Price (K USD/Unit) by Types (2012-2017)
Figure United States Vaccine Adjuvants Sales Growth Rate by Type (2012-2017)
Table United States Vaccine Adjuvants Sales (Units) by Application (2012-2017)
Table United States Vaccine Adjuvants Sales Market Share by Application (2012-2017)
Figure United States Vaccine Adjuvants Sales Market Share by Application (2012-2017)
Figure United States Vaccine Adjuvants Sales Market Share by Application in 2016
Table United States Vaccine Adjuvants Sales Growth Rate by Application (2012-2017)
Figure United States Vaccine Adjuvants Sales Growth Rate by Application (2012-2017)
Table SEPPIC Basic Information List
Table SEPPIC Vaccine Adjuvants Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure SEPPIC Vaccine Adjuvants Sales Growth Rate (2012-2017)
Figure SEPPIC Vaccine Adjuvants Sales Market Share in United States (2012-2017)
Figure SEPPIC Vaccine Adjuvants Revenue Market Share in United States (2012-2017)
Table SDA BIO Basic Information List
Table SDA BIO Vaccine Adjuvants Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure SDA BIO Vaccine Adjuvants Sales Growth Rate (2012-2017)
Figure SDA BIO Vaccine Adjuvants Sales Market Share in United States (2012-2017)
Figure SDA BIO Vaccine Adjuvants Revenue Market Share in United States (2012-2017)
Table Brenntag Biosector Basic Information List
Table Brenntag Biosector Vaccine Adjuvants Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Brenntag Biosector Vaccine Adjuvants Sales Growth Rate (2012-2017)
Figure Brenntag Biosector Vaccine Adjuvants Sales Market Share in United States (2012-2017)
Figure Brenntag Biosector Vaccine Adjuvants Revenue Market Share in United States (2012-2017)
Table SPI Pharma Basic Information List
Table SPI Pharma Vaccine Adjuvants Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure SPI Pharma Vaccine Adjuvants Sales Growth Rate (2012-2017)
Figure SPI Pharma Vaccine Adjuvants Sales Market Share in United States (2012-2017)
Figure SPI Pharma Vaccine Adjuvants Revenue Market Share in United States (2012-2017)
Table MVP Laboratories Basic Information List
Table MVP Laboratories Vaccine Adjuvants Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure MVP Laboratories Vaccine Adjuvants Sales Growth Rate (2012-2017)
Figure MVP Laboratories Vaccine Adjuvants Sales Market Share in United States (2012-2017)
Figure MVP Laboratories Vaccine Adjuvants Revenue Market Share in United States (2012-2017)
Table Tj Kaiwei Basic Information List
Table Tj Kaiwei Vaccine Adjuvants Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Tj Kaiwei Vaccine Adjuvants Sales Growth Rate (2012-2017)
Figure Tj Kaiwei Vaccine Adjuvants Sales Market Share in United States (2012-2017)
Figure Tj Kaiwei Vaccine Adjuvants Revenue Market Share in United States (2012-2017)
Table Novavax Basic Information List
Table Novavax Vaccine Adjuvants Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Novavax Vaccine Adjuvants Sales Growth Rate (2012-2017)
Figure Novavax Vaccine Adjuvants Sales Market Share in United States (2012-2017)
Figure Novavax Vaccine Adjuvants Revenue Market Share in United States (2012-2017)
Table Zhuoyue Basic Information List
Table Zhuoyue Vaccine Adjuvants Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Zhuoyue Vaccine Adjuvants Sales Growth Rate (2012-2017)
Figure Zhuoyue Vaccine Adjuvants Sales Market Share in United States (2012-2017)
Figure Zhuoyue Vaccine Adjuvants Revenue Market Share in United States (2012-2017)
Table Aphios Basic Information List
Table Aphios Vaccine Adjuvants Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Aphios Vaccine Adjuvants Sales Growth Rate (2012-2017)
Figure Aphios Vaccine Adjuvants Sales Market Share in United States (2012-2017)
Figure Aphios Vaccine Adjuvants Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Vaccine Adjuvants
Figure Manufacturing Process Analysis of Vaccine Adjuvants
Figure Vaccine Adjuvants Industrial Chain Analysis
Table Raw Materials Sources of Vaccine Adjuvants Major Players/Suppliers in 2016
Table Major Buyers of Vaccine Adjuvants
Table Distributors/Traders List
Figure United States Vaccine Adjuvants Sales Volume (Units) and Growth Rate Forecast (2017-2022)
Figure United States Vaccine Adjuvants Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Vaccine Adjuvants Price (K USD/Unit) Trend Forecast (2017-2022)
Table United States Vaccine Adjuvants Sales Volume (Units) Forecast by Type (2017-2022)
Figure United States Vaccine Adjuvants Sales Volume (Units) Forecast by Type (2017-2022)
Figure United States Vaccine Adjuvants Sales Volume (Units) Forecast by Type in 2022
Table United States Vaccine Adjuvants Sales Volume (Units) Forecast by Application (2017-2022)
Figure United States Vaccine Adjuvants Sales Volume (Units) Forecast by Application (2017-2022)
Figure United States Vaccine Adjuvants Sales Volume (Units) Forecast by Application in 2022
Table United States Vaccine Adjuvants Sales Volume (Units) Forecast by Region (2017-2022)
Table United States Vaccine Adjuvants Sales Volume Share Forecast by Region (2017-2022)
Figure United States Vaccine Adjuvants Sales Volume Share Forecast by Region (2017-2022)
Figure United States Vaccine Adjuvants Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources